Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
about
Exercise Counteracts Aging-Related Memory Impairment: A Potential Role for the Astrocytic Metabolic ShuttleMitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation ProductsThe 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentRedox control of microglial function: molecular mechanisms and functional significanceProteomics of protein post-translational modifications implicated in neurodegenerationMitochondrial lipids in neurodegenerationRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's diseaseOxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: protein carbonylation is diminished by ascorbic acid.Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer diseasePreclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationBiliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Proteomic identification of carbonylated proteins and their oxidation sitesContinuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profilesOxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brainElevated 4-hydroxyhexenal in Alzheimer's disease (AD) progressionOxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.Qualitative and quantitative evaluation of derivatization reagents for different types of protein-bound carbonyl groups.3,4,5-tri-O-caffeoylquinic acid inhibits amyloid β-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH.The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysisIncreased plasma levels of heat shock protein 70 associated with subsequent clinical conversion to mild cognitive impairment in cognitively healthy elderly4-hydroxy-2-nonenal-modified glyceraldehyde-3-phosphate dehydrogenase is degraded by cathepsin G in rat neutrophils.Protein targets for carbonylation by 4-hydroxy-2-nonenal in rat liver mitochondria.Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia.Dietary antioxidants prevent age-related retinal pigment epithelium actin damage and blindness in mice lacking αvβ5 integrinBiomarkers of lipid peroxidation in Alzheimer disease (AD): an update.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.Protein carbonylation and metabolic control systems.Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.Proteomics in animal models of Alzheimer's and Parkinson's diseases.
P2860
Q26752408-B1F88128-055D-44C6-80A6-5B9A17E50AFFQ26767051-20A98A85-2D05-47F6-9AC9-ABB75D2DF678Q26827320-D8ECD8D7-5F1E-4E3C-B06D-14393A40A1DCQ27000279-DA1297B4-32F5-4A10-AA96-DE397AC19A36Q28088631-C8F021A8-786C-4BEE-8B39-9E4CAE36DFBCQ28397548-0F88E1B3-1372-4B55-B730-77DF66DD1FC5Q30367032-0B17FE01-6D93-4B1B-8182-50E2DDDA5E9EQ30394816-C0169A5A-6B53-4DC0-BD15-65032C07069BQ30446460-7A2FAD57-E627-48E6-A4C4-4924CCC2F1B9Q30505920-0B400EF9-04CD-489A-AEC1-BDC2BC685E32Q33494148-A1C5ABA8-88F4-436E-80C4-5687F6965454Q33506441-E9D2210C-23AF-4BB6-BB54-E539767DCD31Q33639885-E7968E98-BBD4-4320-978E-FFCA34424C6BQ33674371-3B138267-EB7B-4B67-9101-B951D7B68AE7Q33857238-D5520014-5F49-4526-B4E4-68A969FA8C64Q33912803-7EAED281-9BE3-41B3-87E6-ACC04CE47FB8Q33915362-646B2CEA-1034-46DF-AF5D-432802C9C655Q34071097-66409DC1-3D3F-44D7-8866-6696103B7BE4Q34094516-E4DD271D-147B-4972-B54A-B7D2A51F4A74Q34118916-33E8BB9B-F314-4D6D-87C7-714ECA143E58Q34185639-2062680C-4E96-433F-AE3C-BDDB63EF3584Q34268519-C18A61CB-EBD8-49B8-896D-0BEF7A800A5AQ34512386-DF7D6A74-645E-4492-9DCB-7E18133FF72CQ34561160-18815FCA-7D3F-4970-A2A9-38A559514EE2Q34616336-56CC242C-F2B7-4605-9ECB-DABF2219389FQ34802032-ECA7D67D-1164-48F3-81DA-75DD3B296D77Q34827756-9095A726-2F08-4A0E-A9C4-B1B6FDE5E904Q34984799-D0F27BD7-8BB7-4B0D-84A1-8D507B7ED9A4Q35175654-90ED0C89-EB48-40F0-A310-85EB6CE1C0D7Q35195796-7B4C463D-391C-4FA6-A886-75495AB229E9Q35422093-75A44645-91F3-424B-BFB5-5558A30EB7C0Q35606429-F511ED21-4274-4A61-88D1-641B63AD4B52Q35705397-BA4246AE-CA1C-4358-8618-5ECE9CAAD690Q35738877-E0CA8881-D769-4C98-9427-C6BBFA922E95Q36026546-A9683B97-6153-4DBF-9DA6-6FF54A05F16DQ36129390-335124CF-9A3C-4856-B297-A3FD59F8132CQ36243522-E5D90D7A-849A-456A-83E5-4793CF695C6AQ36390685-C78F7BA4-429A-42BC-9BF7-1B28531C5818Q36970130-836C294E-79AA-4526-815B-76A4BCC4D658Q37071539-8565D7B2-37E1-47FF-86D7-422654DE8686
P2860
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Redox proteomic identification ...... enesis of Alzheimer's disease.
@ast
Redox proteomic identification ...... enesis of Alzheimer's disease.
@en
Redox proteomic identification ...... enesis of Alzheimer's disease.
@nl
type
label
Redox proteomic identification ...... enesis of Alzheimer's disease.
@ast
Redox proteomic identification ...... enesis of Alzheimer's disease.
@en
Redox proteomic identification ...... enesis of Alzheimer's disease.
@nl
prefLabel
Redox proteomic identification ...... enesis of Alzheimer's disease.
@ast
Redox proteomic identification ...... enesis of Alzheimer's disease.
@en
Redox proteomic identification ...... enesis of Alzheimer's disease.
@nl
P2093
P50
P1476
Redox proteomic identification ...... enesis of Alzheimer's disease.
@en
P2093
Delano M Turner
Jon B Klein
Marzia Perluigi
Rukhsana Sultana
William M Pierce
William R Markesbery
P304
P356
10.1016/J.NBD.2007.12.007
P577
2008-01-05T00:00:00Z